Vertex returns positive data on hepatitis C drug trial

Vertex returns positive data on hepatitis C drug trial
Vertex Pharmaceuticals Inc., the Cambridge-based small molecule drug maker, has reported positive data from a Phase 3 trial of a treatment for patients with hepatitis C.

Read more on Mass High Tech: The Journal of New England Technology

More Meth Drug Addiction Info:

• Recall & Redeploy the AZ National Guard! « Phase 3
• Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Bucks Trend
• Phase 3 pt 17 (Discovering the Balance) | Make Money And Self …
• Mass High Tech Panel Explores ways Clean Tech Companies can Better …
• Vertex Gets Strong Results From Hepatitis C Trial, Anadys Explores …
• Vertex Hepatitis C Drug Passes Pivotal Test, Cures Three Out of …
• FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial …
• MITRE's Jill Drury Named a Mass High Tech “Woman to Watch” | TTKN News
• STAX Systems – Phase 3 Carbohydrate Cycling | Straight Reviews …
• Waltman Diagnosed With Hepatitis C, Homicide Working Injured